Loading company…
Phanes Therapeutics develops antibody-based drugs for immuno-oncology and eye diseases.
Founded in 2016 and based in San Diego, Phanes Therapeutics researches drugs for immuno-oncology and eye diseases. Its PACbody platform builds native IgG-like bispecific antibodies, while ATACCbody develops bispecific antibodies with modulated activity. The company was founded by CEO Dr.Wang Minghan, formerly a vice president at Johnson & Johnson.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in